scholarly journals A 12-MONTH, MULTICENTER, RANDOMIZED, ADAPTIVE DESIGN, OPEN-LABEL STUDY TO EVALUATE THE BENEFIT OF C2 HOUR MONITORING OF NEORAL ON SAFETY AND EFFICACY OUTCOMES IN DE NOVO CARDIAC TRANSPLANT RECIPIENTS RECEIVING BASILIXIMAB INDUCTION

2004 ◽  
Vol 78 ◽  
pp. 420
Author(s):  
M Cantarovich ◽  
H Ross ◽  
J Arizon ◽  
M A. Gomez ◽  
L Straatman ◽  
...  
Keyword(s):  
Adaptive Design ◽  
De Novo ◽  
Cardiac Transplant ◽  
Transplant Recipients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Safety And Efficacy

Everolimus and Reduced-Exposure Cyclosporine in de novo Renal-Transplant Recipients: A Three-Year Phase II, Randomized, Multicenter, Open-Label Study

2004 ◽  
Vol 78 (9) ◽  
pp. 1332-1340 ◽  
Author(s):  
Bj??rn Nashan ◽  
John Curtis ◽  
Claudio Ponticelli ◽  
Georges Mourad ◽  
Jonathan Jaffe ◽  
...  
Keyword(s):  
Renal Transplant ◽  
Phase Ii ◽  
De Novo ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document